CONTROVERSIES INVOLVING INHALED β-AGONISTS AND INHALED CORTICOSTEROIDS IN THE TREATMENT OF ASTHMA
- 1 December 1995
- journal article
- Published by Elsevier in Clinics in Chest Medicine
- Vol. 16 (4) , 715-733
- https://doi.org/10.1016/s0272-5231(21)01173-4
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Budesonide treatment of moderate and severe asthma in children: A dose-response studyJournal of Allergy and Clinical Immunology, 1995
- Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthmaJournal of Allergy and Clinical Immunology, 1994
- Questions about inhaled β2-adrenoceptor agonists in asthmaTrends in Pharmacological Sciences, 1992
- Comparison of oral-steroid sparing by high-dose and low-dose inhaled steroid in maintenance treatment of severe asthmaThe Lancet, 1992
- A double‐blind dose‐response study of budesonide by inhalation in patients with bronchial asthmaAllergy, 1988
- Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonideJournal of Allergy and Clinical Immunology, 1982
- Regular versus symptomatic aerosol bronchodilator treatment of asthmaRespiratory Medicine, 1981
- Double-blind trial comparing two dosage schedules of beclomethasone dipropionate aerosol with a placebo in chronic bronchial asthmaRespiratory Medicine, 1979
- Beclomethasone dipropionate in long-term treatment of asthma in childrenThe Journal of Pediatrics, 1976
- Clinical effects of epinephrine by inhalationJournal of Allergy, 1948